The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
Trending
- Meet the Peaky Blinders, Ukraine’s drone unit protecting a devastated front-line city
- Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
- Violence erupts in Bangladesh as ousted PM’s supporters stage protest
- Watch: E-bike battery explodes into massive fireball inside Oregon home
- Spain’s king and queen attend memorial service for rail crash victims
- Meghan’s father Thomas Markle detained for allegedly cutting off ankle monitor, officials say
- Nvidia hires major New York law firm to investigate Jensen Huang affair
- Schumer accuses Trump of defending Nvidia CEO Jensen Huang at cost of national security